Person

Teri L. Lawver

Formerly EVP Chief Commercial Officer, Dexcom

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$640K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • DXCM
    Dexcom
    EVP Chief Commercial Officer
    Jan 2023 – last filing Mar 2024

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 12, 2024DXCMSale4,764$134.41$640K

SEC reporting-owner ID (CIK) 1960596 · all filings on EDGAR